PhagoMed is a pre-clinical biotech company developing phage-based pharmaceuticals to combat the antibiotics crisis.

Building on more than twenty years of clinical and scientific expertise in phage therapy, PhagoMed was founded in 2017 by a team of seasoned medical and pharmaceutical professionals with the aim of bringing phage-based pharmaceuticals to market in select indications of high medical need. The initial research program focuses on Periprosthetic Joint Infections as well as Urinary Tract Infections.

PhagoMed Biopharma GmbH
Dr-Bohr-Gasse 2-8/14/1
1030 Vienna
Building: Map